August 2, 2022
PAR-22-073 - Innovation Corps (I-Corps™) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)
National Cancer Institute (NCI)
The purpose of this Notice is to inform potential applicants that following cohort dates are scheduled in FY2023 for PAR-22-073, “Innovation Corps (I-Corps™) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed).” This notice also informs all potential applicants that all required workshops of the program will be conducted virtually. Finally, this notice informs that the third cohort in FY2023 (July 10th – August 29th) is specifically designed for very early-stage Phase I SBIR/STTR (NIH only) awards from NCI such as those funded under Small Business Transition Grant.
The following changes and updates are made to PAR-22-073 (shown in italics) to reflect cohort dates and venue for the cohorts of FY2023 in this FOA.
Currently Reads:
Details for the FY2022 cohorts are given below. All team members accepted to the I-Corps at NIH are required to participate in each of the program events given below. Additional dates will be released by Notice.
Modified to read (in italics):
Details for the FY2023 cohorts are given below. All team members accepted to the I-Corps at NIH are required to participate in each of the program events given below.
Cohort 1 | Cohort 2 | Cohort 3 | |
Application Due Date | November 16, 2022 | February 1, 2023 | May 2, 2023 |
Phone Interview | January 9 - 10, 2023 | March 6-7, 2023 | May 29-30, 2023 |
Kick-off/Close-out Venue | Virtual | Virtual | Virtual |
Course Kick-off | March 6 - 9, 2023 | May 8-11, 2023 | July 10 -13, 2023 |
Virtual Webinars |
March 15, 2022 |
May 17, 2022 |
July 19, 2022 |
April 24-25, 2023 | |||
Course Close-out | June 26-27, 2023 | August 28-29, 2023 | |
Cohort Size | 24 Teams | 24 Teams | 8-16 Teams |
Reema Railkar, Ph.D.
National Cancer Institute (NCI)
Phone: 240-276-5720
Email: [email protected]